Biopolym. Cell. 2011; 27(5):354-358.
Mutations in MEFV cause alterations in neutrophil
F-actin and phagocytosis dynamics
- "Armenicum" Research Centre, CJSC Armenicum
37, Nalbandyan Str., Yerevan, Republic of Armenia, 0001 - Yerevan State Medical University named after Mkhitar Heratsi, Ministry of Education and Science of Republic of Armenia
2, Koryun Str., Yerevan, Republic of Armenia, 0025
Abstract
Aim. To examine neutrophil F-actin, phagocytosis and macropinocytosis dymanics in patients with Familial Mediterranean Fever (FMF), in an effort to understand the mechanisms that regulate switch of neutrophil activation program. Methods. Whole blood neutrophils obtained from 37 attack-free FMF patients and 20 normal donors (ND) were activated with N-formyl-Met-Leu-Phe (fMLP), phorbolmyristate acetate (PMA) or lipo- polysaccharide (LPS) and cellular F-actin content, phagocytosis and macropinocytosis determined by flow cytometry. F-actin oscillation amplitude and period were calculated from the curves generated by mathematical simulation giving the assumption that in neutrophil F-actin oscillates about a fixed point in a harmonic motion. Results. Unstimulated neutrophil F-actin content was markedly increased in FMF patients. fMLP- but not PMA- or LPS-stimulated and Col-pretreated neutrophils where characterized by different pattern of F-actin dynamics and delayed time period of F-actin oscillation during FMF. Neutrophils from FMF patients failed to induce chemoattractant receptor desensitization during repeated action of fMLP, while in ND it occurred with significant reduction of F-actin oscillation amplitude and period. In FMF patients we observed significant enhancement of phagocytosis but not macropinocytosis amplitude and frequency. Conclusions. Impaired neutrophil F-actin, phagocytosis and macropinocytosis oscillations amplitude and frequency that tightly regulate switch of neutrophil activation program during its encounter with increasing concentration of chemoattractants may be a potential pathogenic mechanism causing aberrant resolution of inflammation during FMF.
Keywords: familial Mediterranean fever, neutrophil, F-actin, phagocytosis, macropinocytosis, N-formyl-Met-Leu-Phe, phorbolmyristate acetate
Full text: (PDF, in English)
References
[1]
Centola M., Wood G., Frucht D. M., Galon J., Aringer M., Farrell C., Kingma D. W., Horwitz M. E., Mansfield E., Holland S. M., O'Shea J. J., Rosenberg H. F., Malech H. L., Kastner D. L. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators Blood 2000 95, N 10 P. 3223– 3231.
[2]
Shoham N. G., Centola M., Mansfield E., Hull K. M., Wood G., Wise C. A., Kastner D. L. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway Proc. Natl. Acad. Sci. USA 2003 100, N 23 P. 13501–13506.
[3]
Jeru I., Papin S., L'hoste S., Duquesnoy P., Cazeneuve C., Camonis J., Amselem S. Interaction of pyrin with 14.3.3 in an isoform-specific and phosphorylation-dependent manner regulates its translocation to the nucleus Arthritis Rheum 2005 52, N 6 P. 1848–1857.
[4]
Chae J. J., Wood G., Masters S. L., Richard K., Park G., Smith B. J., Kastner D. L. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production Proc. Natl. Acad. Sci. USA 2006 103, N 26 P. 9982–9987.
[5]
Richards N., Schaner P., Diaz A., Stuckey J., Shelden E., Wadhwa A., Gumucio D. L. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis J. Biol. Chem 2001 276, N 42 P. 39320–39329.
[6]
Balci-Peynircioglu B., Waite A. L., Hu C., Richards N., Staubach-Grosse A., Yilmaz E., Gumucio D. L. Pyrin, product of the MEFV locus, interacts with the proapoptotic protein, Siva J. Cell Physiol 2008 216, N 3 P. 595–602.
[7]
Mansfield E., Chae J. J., Komarow H. D., Brotz T. M., Frucht D. M., Aksentijevich I., Kastner D. L. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments Blood 2001 98, N 3 P. 851–859.
[8]
Livneh A., Langevitz P., Zemer D., Zaks N., Kees S., Lidar T., Migdal A., Padeh S., Pras M. Criteria for the diagnosis of familial Mediterranean fever Arthritis Rheum 1997 40, N 10 P. 1879–1885.
[9]
Advani A., Marshall S. M., Thomas T. H. Increasing neutrophil F-actin corrects CD11b exposure in Type 2 diabetes Eur. J. Clin. Invest 2004 34, N 5 P. 358–364.
[10]
Stark J., Chan C., George A. J. Oscillations in the immune system Immunol. Rev 2007 216 P. 213–231.
[11]
Ali H., Richardson R. M., Haribabu B., Snyderman R. Chemoattractant receptor cross-desensitization J. Biol. Chem 1999 274, N 10 P. 6027–6030.